CID-078

· Circle Pharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CID-078, covering 2025-09-15 to 2025-09-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies [Phase 1]